National Register of Actionable Mutations
National Register of Actionable Mutations
Active, not recruiting · NCT05918666 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| National Register of Actionable Mutations | Solid Tumours in Advanced Stages | Active, not recruiting | Not stated | 2026-01-30 | NCT05918666 |
12 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
| AstraZeneca | 806 |
| Bayer | 178 |
| Bristol-Myers Squibb | 422 |
| Clinical Research Technology S.r.l. | 8 |
| Daiichi Sankyo | 144 |
| Eli Lilly and Company | 370 |
| Federation of Italian Cooperative Oncology Groups | 1 |
| Janssen, LP | 23 |
| Novartis | 114 |
| Roche Pharma AG | 59 |
| Takeda | 163 |
43 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.